PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection.
One quarter of the world’s population is infected with latent tuberculosis (LTBI), also known as inactive tuberculosis. One in ten people with LTBI will progress to active TB disease.
It is essential to develop newer diagnostic tests with significantly increased predictive value for the development of active disease among those who are infected than the currently available tests for LTBI (WHO, 2017).
At PBD Biotech, our mission is to support the scale-up of latent tuberculosis test-and-treat campaigns with Actiphage to achieve the goals of the WHO End TB strategy. Leveraging Actiphage’s unique role in detecting active TB, PBD aims to drive innovation in the novel uses for TB screening and drug management.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Birmingham, B3 1rb, Gb
- Phone
- +44 (0) 1359 231856
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pbdbio.com
- Keywords
- intoDNA.
- HQ
- Birmingham
Pbd Biotech Questions
Pbd Biotech's helpline number is +44 (0) 1359 231856
Pbd Biotech's website is pbdbio.com
Pbd Biotech's LinkedIn profile is https://uk.linkedin.com/company/pbd-biotech
Pbd Biotech has
8 employees.
View email and phone details for 8
employees at Pbd Biotech.
Pbd Biotech's industry is
Biotechnology Research
Pbd Biotech's top competitors are
Mabsolve,
Mercy Bioanalytics, Inc.,
Absolute Antibody,
Intodna,
Xgenera,
Gamma Proteins,
K4 Creative,
Go Therapeutics,
Arcticzymes Technologies Asa,
Iceni Glycoscience (Formerly Iceni Diagnostics).
Pbd Biotech's support email address is info@pbdbio.com
Pbd Biotech's categories are Biotechnology Research
Pbd Biotech's founding year is 2016
